Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT05935826
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Adolescent Obesity
- Hepatic Steatosis
- NAFLD
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Essential Amino Acid Supplement by Amino Co — DRUG2 months of twice daily consumption of Purity (EAA), followed by 10 months open label extension of EAA
- Placebo — OTHER2 months of twice daily consumption of Placebo, followed by 10 months open label extension of EAA
Study Details
Participants 13-18 years of age with extra fat stored in the liver will be randomly assigned to a protein supplement or placebo "fake supplement" for 2 months to see if the participants who get the protein supplement have less fat in the liver compared to participants who were in the placebo group. After the 2 month intervention, all participants can continue the study and will all receive the protein supplement for an additional 10-months.
Key Dates
- Start date
- Jun 18, 2024
- Status verified
- Aug 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 55 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Amino Acid SupplementParticipants are blindly randomized and for this arm, participants will take the Essential Amino Acid Supplement for 2-months, followed by an open label extension period of 10-months of Essential Amino Acid for all participants
- Placebo Comparator: PlaceboParticipants are blindly randomized and for this arm, participants will take the Placebo for 2-months, followed by an open label extension period of 10-months of Essential Amino Acid for all participants
Primary Outcome Measure
Change in Hepatic Fat Fraction [ Time Frame: Baseline and 8 weeks ]
Central Contacts
- Yesenia Garcia Reyes, MS720-777-6984
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Univeristy of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | Melanie Cree, MD,PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
By research site
Related Studies
- Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)Recruiting · Petter Bjornstad · Aurora, Colorado
- Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up StudyEnrolling By Invitation · University of Colorado, Denver · Aurora, Colorado
- Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in AdolescentsPHASE1 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Reversal of Lipid-Induced Insulin ResistanceRecruiting · Yale University · New Haven, Connecticut